The Middle EAST End Stage Renal Disease Market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.1 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several key factors, including an increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, and a rising awareness of kidney health among the population....